ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 088,24
0,89%
Dow Jones
38 239,66
0,40%
DAX
18 161,01
1,32%
Brent Oil
88,165
0,00%
Bitcoin
63 632,73
0,35%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Royaume-Uni
  5. LSE
  6. Allergy Therapeutics Plc (AGY)

  7. Allergy Therapeutics Plc (AGY) Actualités

AGY Allergy Therapeutics Plc

2,85
0,00 (0,00%)
26 Avr 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Allergy Therapeutics Plc AGY London Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,00 0,00% 2,85 09:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
2,85 2,85 2,85 2,85 2,85
plus d'informations sur les cotations »
Secteur Industriel
PHARMACEUTICALS & BIOTECHNOLOGY

Actualités Recentes

Date Heure Source Titre
03/4/202408:00UK RNSAllergy Therapeutics PLC Director Resignation
27/3/202417:13ALNCNewsEARNINGS AND TRADING: Solid State ups outlook; Quartix..
27/3/202408:00UK RNSAllergy Therapeutics PLC Interim Results for six months..
27/3/202408:00UK RNSAllergy Therapeutics PLC Update on funding
12/3/202415:06ALNCNewsAllergy Therapeutics starts dosing patients in peanut..
12/3/202409:59UK RNSAllergy Therapeutics PLC VLP Peanut PROTECT Trial Update
12/3/202408:00UK RNSAllergy Therapeutics PLC VLP Peanut PROTECT Trial Update
11/3/202408:00UK RNSAllergy Therapeutics PLC Appointment of Shaun Furlong to..
08/3/202414:49UK RNSAllergy Therapeutics PLC Result of AGM
14/2/202411:22ALNCNewsAllergy Therapeutics forecasts revenue drop but trials going..
14/2/202408:00UK RNSAllergy Therapeutics PLC Half-Year Trading Update 2024
09/2/202416:07UK RNSAllergy Therapeutics PLC Notice of 2023 Annual General..
30/1/202411:38ALNCNewsAllergy Therapeutics resumes trading on AIM; annual revenue..
30/1/202408:30UK RNSAIM Restoration - Allergy Therapeutics plc
30/1/202408:00UK RNSAllergy Therapeutics PLC Publication of Annual Report and..
04/1/202413:29UKREGAllergy Therapeutics PLC Total Voting Rights
02/1/202408:30UKREGAIM Suspension - Allergy Therapeutics plc
27/12/202315:17ALNCNewsIN BRIEF: Allergy Therapeutics amends facility, plans..
27/12/202313:01UKREGAllergy Therapeutics PLC Amendment to existing Facility..
15/12/202322:09ALNCNewsEARNINGS AND TRADING: Redx full year revenue tumbles; loss..
15/12/202313:48UKREGAllergy Therapeutics PLC Annual Report and Accounts Delayed
13/12/202317:54UKREGAllergy Therapeutics PLC PDMR dealing and Total Voting..
13/12/202311:11ALNCNewsAllergy Therapeutics shares jump as hails grass allergy jab..
13/12/202308:00UKREGAllergy Therapeutics PLC G306 Phase III trial meets key..
11/12/202311:40ALNCNewsIN BRIEF: Allergy Therapeutics stock falls on lower sales..
11/12/202308:00UKREGAllergy Therapeutics PLC Update on funding
01/12/202308:00UKREGAllergy Therapeutics PLC Total Voting Rights
28/11/202316:03UKREGAllergy Therapeutics PLC Holding(s) in Company
14/11/202312:56ALNCNewsAllergy Therapeutics says allergy therapy trial meets..
14/11/202308:00UKREGAllergy Therapeutics PLC G306 Grass Phase III trial meets..
10/11/202315:39UKREGPanmure Gordon (UK) Limited Form 8.5 (EPT/RI)
10/11/202314:22UKREGAllergy Therapeutics PLC Director/PCA Dealing
10/11/202314:11UKREGAllergy Therapeutics PLC Holding(s) in Company
10/11/202308:00UKREGZQ Capital Limited Offer Closure
09/11/202311:48UKREGAllergy Therapeutics PLC Exercise of Options and Total..
09/11/202310:25UKREGPanmure Gordon (UK) Limited Form 8.5 (EPT/RI)
09/11/202310:15UKREGCavendish Securities PLC Form 8.5 (EPT/NON-RI)
08/11/202311:45UKREGPanmure Gordon (UK) Limited Form 8.5 (EPT/RI)
07/11/202312:10UKREGPanmure Gordon (UK) Limited Form 8.5 (EPT/RI)
06/11/202313:33ALNCNewsIN BRIEF: Allergy Therapeutics extends cash runway until end..
06/11/202310:33UKREGPanmure Gordon (UK) Limited Form 8.5 (EPT/RI)
06/11/202308:00UKREGAllergy Therapeutics PLC Update on funding
03/11/202310:31UKREGPanmure Gordon (UK) Limited Form 8.5 (EPT/RI)
02/11/202311:24UKREGPanmure Gordon (UK) Limited Form 8.5 (EPT/RI)
01/11/202311:23UKREGPanmure Gordon (UK) Limited Form 8.5 (EPT/RI)
31/10/202309:30UKREGPanmure Gordon (UK) Limited Form 8.5 (EPT/RI)
30/10/202311:06UKREGPanmure Gordon (UK) Limited Form 8.5 (EPT/RI)
27/10/202312:33UKREGPanmure Gordon (UK) Limited Form 8.5 (EPT/RI)
26/10/202311:07UKREGPanmure Gordon (UK) Limited Form 8.5 (EPT/RI)
25/10/202310:48UKREGCavendish Securities PLC Form 8.5 (EPT/NON-RI)

Dernières Valeurs Consultées

LSE
AGY
Allergy Therapeutics
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés